Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Roche Holding AG

RHHVF
Current price
313.9 USD +5.81 USD (+1.89%)
Last closed 293.2 CHF
ISIN CH0012032113
Sector Healthcare
Industry Drug Manufacturers - General
Exchange SW
Capitalization 223 294 352 616 CHF
Yield for 12 month +17.61 %
1Y
3Y
5Y
10Y
15Y
RHHVF
21.11.2021 - 28.11.2021

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland. Address: Grenzacherstrasse 124, Basel, Switzerland, 4058

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

217.53 CHF

P/E ratio

23.2024

Dividend Yield

3.08 %

Current Year

+58 590 703 363 CHF

Last Year

+63 145 961 909 CHF

Current Quarter

+29 784 306 049 CHF

Last Quarter

+28 875 250 071 CHF

Current Year

+42 806 458 083 CHF

Last Year

+44 349 159 007 CHF

Current Quarter

+21 931 100 185 CHF

Last Quarter

+20 612 919 125 CHF

Key Figures RHHVF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 20 996 100 138 CHF
Operating Margin TTM 35.27 %
PE Ratio 23.2024
Return On Assets TTM 12.49 %
PEG Ratio 1.3208
Return On Equity TTM 36.36 %
Wall Street Target Price 217.53 CHF
Revenue TTM 60 451 722 727 CHF
Book Value 36.25 CHF
Revenue Per Share TTM
Dividend Share 9.58 CHF
Quarterly Revenue Growth YOY 0.5 %
Dividend Yield 3.08 %
Gross Profit TTM 47 725 937 741 CHF
Earnings per share 13.21 CHF
Diluted Eps TTM 13.21 CHF
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -12.1 %
Profit Margin 17.53 %

Dividend Analytics RHHVF

Aristocrat - 25 or more consecutive years of dividend increases

Dividend growth over 5 years

14 %

Continuous growth

27 years

Payout Ratio 5 years average

57 %

Dividend History RHHVF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 9.6
Ex Dividend Date 14.03.2024
Forward Annual Dividend Yield 3.13 %
Last Split Factor 100:1
Payout Ratio 116.36 %
Last Split Date 04.05.2011
Dividend Date 18.03.2024

Stock Valuation RHHVF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 23.2024
Forward PE 14.7929
Enterprise Value Revenue 4.1673
Price Sales TTM 3.6938
Enterprise Value EBITDA 14.2551
Price Book MRQ 8.4574

Financials RHHVF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators RHHVF

For 52 weeks

226.42 CHF 311.33 CHF
50 Day MA 293.8 CHF
Shares Short Prior Month
200 Day MA 268.34 CHF
Short Ratio
Shares Short
Short Percent